Leukotriene Receptor Antagonist [EPC]

Leukotriene Receptor Antagonist [EPC] was reported 29263 times

Drugs of the Leukotriene Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 RIGHT ATRIAL HYPERTROPHY 56 0.5091
1 HEART SOUNDS 32 0.3333
2 EJECTION FRACTION 191 0.3287
3 SENSITISATION 246 0.3241
4 RHINITIS PERENNIAL 20 0.2500
5 PULMONARY VASCULITIS 122 0.2268
6 PROLONGED EXPIRATION 55 0.2099
7 TOTAL LUNG CAPACITY ABNORMAL 75 0.1928
8 SALPINGO-OOPHORECTOMY UNILATERAL 21 0.1909
9 CAPILLARITIS 52 0.1884
10 SPIROMETRY ABNORMAL 100 0.1672
11 POLYCYSTIC OVARIES 241 0.1553
12 MITE ALLERGY 93 0.1420
13 TEMPERATURE REGULATION DISORDER 268 0.1202
14 HUMAN RHINOVIRUS TEST POSITIVE 44 0.1180
15 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 57 0.1090
16 DUST ALLERGY 100 0.1019
17 MYCOTIC ALLERGY 87 0.1018
18 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 187 0.0916
19 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 62 0.0846
20 VIRAL TEST POSITIVE 30 0.0826
21 BRONCHIAL WALL THICKENING 58 0.0807
22 VITAL CAPACITY DECREASED 35 0.0781
23 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 71 0.0766
24 ASTHMA EXERCISE INDUCED 26 0.0747
25 RHINITIS ALLERGIC 331 0.0743
26 PNEUMONIA HAEMOPHILUS 36 0.0741
27 VOCAL CORD DYSFUNCTION 36 0.0730
28 PULMONARY FUNCTION TEST ABNORMAL 109 0.0699
29 NEURITIS 108 0.0699
30 CONJUNCTIVITIS ALLERGIC 100 0.0675
31 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 45 0.0640
32 SPUTUM PURULENT 42 0.0638
33 EJECTION FRACTION ABNORMAL 78 0.0636
34 RESPIRATORY SYMPTOM 178 0.0625
35 RIGHT VENTRICULAR HYPERTROPHY 56 0.0620
36 OBSTRUCTIVE SLEEP APNOEA SYNDROME 83 0.0569
37 NASAL OEDEMA 102 0.0564
38 BRONCHIAL SECRETION RETENTION 71 0.0557
39 DYSPLASTIC NAEVUS 20 0.0554
40 OBSESSIVE-COMPULSIVE SYMPTOM 20 0.0542
41 LARYNGEAL STENOSIS 31 0.0536
42 FOOD ALLERGY 412 0.0533
43 NEPHRECTOMY 75 0.0505
44 NASAL TURBINATE HYPERTROPHY 19 0.0504
45 PHOTODERMATOSIS 21 0.0498
46 FOETAL DEATH 254 0.0489
47 FACTOR V LEIDEN MUTATION 19 0.0479
48 ALLERGIC GRANULOMATOUS ANGIITIS 39 0.0475
49 INFUSION SITE DISCHARGE 83 0.0473
50 FULL BLOOD COUNT ABNORMAL 500 0.0472
51 OBSTRUCTIVE AIRWAYS DISORDER 525 0.0471
52 FORCED EXPIRATORY VOLUME DECREASED 127 0.0448
53 NEUROPSYCHOLOGICAL SYMPTOMS 27 0.0448
54 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 744 0.0438
55 MAST CELL ACTIVATION SYNDROME 59 0.0420
56 EOSINOPHIL COUNT ABNORMAL 30 0.0402
57 SLEEP TERROR 164 0.0389
58 CHRONIC SINUSITIS 141 0.0375
59 REVERSIBLE AIRWAYS OBSTRUCTION 19 0.0374
60 BLOOD IMMUNOGLOBULIN E INCREASED 88 0.0363
61 BRONCHIAL HYPERREACTIVITY 43 0.0357
62 PRECANCEROUS CONDITION 23 0.0343
63 ALLERGIC SINUSITIS 29 0.0338
64 SINUSITIS FUNGAL 27 0.0337
65 CHRONIC SPONTANEOUS URTICARIA 39 0.0336
66 NEUROPSYCHIATRIC SYMPTOMS 30 0.0332
67 AORTIC VALVE STENOSIS 59 0.0331
68 TOTAL LUNG CAPACITY DECREASED 50 0.0313
69 ASTHMA 3518 0.0311
70 NASAL DISCHARGE DISCOLOURATION 42 0.0304
71 WHEEZING 1697 0.0286
72 NORMOCHROMIC NORMOCYTIC ANAEMIA 84 0.0279
73 SEASONAL ALLERGY 390 0.0275
74 DIASTOLIC DYSFUNCTION 84 0.0272
75 BREATH SOUNDS ABNORMAL 128 0.0259
76 COELIAC DISEASE 251 0.0256
77 IMMUNODEFICIENCY 380 0.0255
78 INFUSION SITE MASS 27 0.0248
79 PERIORBITAL PAIN 21 0.0248
80 ADJUSTMENT DISORDER 32 0.0246
81 ALLERGY TO ANIMAL 26 0.0244
82 OBSTRUCTION 97 0.0243
83 SOLAR LENTIGO 23 0.0242
84 NASAL POLYPS 119 0.0241
85 SLEEP APNOEA SYNDROME 459 0.0240
86 SPUTUM DISCOLOURED 228 0.0240
87 ASTHMATIC CRISIS 87 0.0238
88 RALES 138 0.0237
89 INFUSION SITE HAEMORRHAGE 78 0.0237
90 DIAPHRAGMATIC DISORDER 18 0.0235
91 BLOOD TEST ABNORMAL 330 0.0235
92 INFUSION SITE BRUISING 50 0.0231
93 INFUSION SITE WARMTH 28 0.0228
94 RHONCHI 31 0.0224
95 MULTIPLE ALLERGIES 175 0.0223
96 CHEST X-RAY ABNORMAL 66 0.0215
97 BRONCHIECTASIS 143 0.0212
98 PULMONARY ALVEOLAR HAEMORRHAGE 119 0.0212
99 CARPAL TUNNEL SYNDROME 292 0.0208
100 BURSITIS 250 0.0206
101 INFUSION SITE PRURITUS 65 0.0206
102 BRONCHIAL OBSTRUCTION 28 0.0199
103 NEUROLOGICAL SYMPTOM 113 0.0197
104 LUNG OPACITY 52 0.0197
105 TONGUE BITING 40 0.0194
106 EYELID PAIN 38 0.0187
107 SPUTUM INCREASED 40 0.0185
108 RHINITIS 148 0.0183
109 UPPER RESPIRATORY TRACT INFECTION 848 0.0183
110 INFUSION SITE ERYTHEMA 154 0.0182
111 DYSPNOEA AT REST 52 0.0179
112 RESTRICTIVE PULMONARY DISEASE 21 0.0179
113 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 24 0.0178
114 PRESCRIBED OVERDOSE 331 0.0171
115 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 797 0.0166
116 PO2 DECREASED 19 0.0165
117 INFUSION SITE IRRITATION 21 0.0163
118 ARTERIOSCLEROSIS CORONARY ARTERY 108 0.0163
119 UPPER-AIRWAY COUGH SYNDROME 134 0.0162
120 INFUSION SITE SWELLING 101 0.0160
121 FEMALE GENITAL TRACT FISTULA 27 0.0158
122 PRODUCTIVE COUGH 745 0.0156
123 PLEURITIC PAIN 43 0.0156
124 BRONCHIAL DISORDER 24 0.0154
125 INFUSION SITE INDURATION 22 0.0148
126 INFUSION SITE RASH 20 0.0146
127 ISCHAEMIC CARDIOMYOPATHY 44 0.0143
128 BENIGN PROSTATIC HYPERPLASIA 74 0.0143
129 CATAPLEXY 20 0.0141
130 INFUSION SITE PAIN 181 0.0140
131 EOSINOPHIL COUNT INCREASED 115 0.0138
132 RESPIRATORY TRACT INFECTION 356 0.0137
133 EOSINOPHILIA 222 0.0127
134 HYPOTHYROIDISM 403 0.0126
135 RESPIRATORY TRACT CONGESTION 200 0.0126
136 FIBROMYALGIA 304 0.0125
137 VASCULITIS 144 0.0123
138 MIDDLE INSOMNIA 229 0.0123
139 SINUS OPERATION 29 0.0122
140 INCREASED BRONCHIAL SECRETION 31 0.0121
141 PULMONARY FUNCTION TEST DECREASED 53 0.0121
142 PRODUCT ADMINISTRATION INTERRUPTED 95 0.0121
143 DEVICE INFUSION ISSUE 30 0.0121
144 DEPRESSIVE SYMPTOM 42 0.0119
145 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 845 0.0119
146 IMPAIRED QUALITY OF LIFE 170 0.0118
147 TIC 61 0.0112
148 PNEUMONIA VIRAL 35 0.0110
149 PRE-EXISTING CONDITION IMPROVED 68 0.0109
150 BODY TEMPERATURE ABNORMAL 20 0.0109
151 TERMINAL INSOMNIA 19 0.0107
152 RESPIRATION ABNORMAL 73 0.0106
153 PULMONARY FIBROSIS 203 0.0106
154 ARTERIOSCLEROSIS 98 0.0104
155 RESPIRATORY TRACT INFECTION VIRAL 24 0.0103
156 DYSPNOEA EXERTIONAL 388 0.0103
157 NIGHTMARE 350 0.0101
158 RESPIRATORY SYNCYTIAL VIRUS INFECTION 87 0.0100
159 CYSTIC FIBROSIS 54 0.0097
160 EMPHYSEMA 96 0.0095
161 ATTENTION DEFICIT HYPERACTIVITY DISORDER 40 0.0095
162 GASTROOESOPHAGEAL REFLUX DISEASE 764 0.0095
163 INFUSION SITE INFECTION 22 0.0095
164 INTERVERTEBRAL DISC DEGENERATION 87 0.0094
165 OBSESSIVE-COMPULSIVE DISORDER 75 0.0093
166 HORDEOLUM 39 0.0090
167 SOMNAMBULISM 59 0.0090
168 SINUS DISORDER 178 0.0090
169 CONTRAINDICATED PRODUCT ADMINISTERED 271 0.0089
170 RASH ERYTHEMATOUS 426 0.0089
171 EMBOLISM VENOUS 27 0.0089
172 ACTINIC KERATOSIS 23 0.0089
173 DEREALISATION 19 0.0088
174 BLOOD COUNT ABNORMAL 133 0.0088
175 FLUID RETENTION 442 0.0087
176 SECRETION DISCHARGE 106 0.0085
177 SELF-INJURIOUS IDEATION 35 0.0083
178 DERMATITIS CONTACT 95 0.0083
179 NASAL CONGESTION 489 0.0083
180 HOSTILITY 21 0.0083
181 EOSINOPHILIC PNEUMONIA 26 0.0082
182 SINUSITIS 843 0.0082
183 OCULAR DISCOMFORT 91 0.0081
184 CUSHINGOID 26 0.0081
185 HAEMOPTYSIS 225 0.0081
186 INSURANCE ISSUE 122 0.0080
187 BRONCHIOLITIS 28 0.0079
188 PARANASAL SINUS DISCOMFORT 30 0.0079
189 ENURESIS 32 0.0079
190 NODULE 102 0.0078
191 COUGH 2188 0.0078
192 PULMONARY MASS 116 0.0078
193 INFUSION SITE REACTION 23 0.0077
194 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 50 0.0077
195 HYPOXIA 271 0.0077
196 APPETITE DISORDER 50 0.0075
197 PULMONARY PAIN 22 0.0075
198 PNEUMONIA BACTERIAL 69 0.0075
199 BRONCHITIS 556 0.0075
200 EAR INFECTION 199 0.0075
201 EXPOSURE DURING PREGNANCY 457 0.0073
202 CHEST DISCOMFORT 743 0.0072
203 MOUTH HAEMORRHAGE 53 0.0072
204 GESTATIONAL DIABETES 34 0.0071
205 DECREASED IMMUNE RESPONSIVENESS 70 0.0071
206 DRUG TOLERANCE DECREASED 20 0.0071
207 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 371 0.0071
208 HIATUS HERNIA 91 0.0070
209 SINUS CONGESTION 94 0.0070
210 SNEEZING 156 0.0069
211 DEPRESSION SUICIDAL 24 0.0069
212 OROPHARYNGEAL DISCOMFORT 62 0.0069
213 PARANASAL SINUS HYPERSECRETION 26 0.0068
214 LOWER RESPIRATORY TRACT INFECTION 307 0.0067
215 LUNG DISORDER 330 0.0067
216 BRONCHOSPASM 95 0.0067
217 PHARYNGEAL SWELLING 65 0.0066
218 OEDEMA 359 0.0066
219 BLOOD CALCIUM INCREASED 58 0.0066
220 CARDIAC MURMUR 57 0.0066
221 DECREASED ACTIVITY 71 0.0066
222 HAEMOGLOBIN INCREASED 30 0.0066
223 SOCIAL AVOIDANT BEHAVIOUR 38 0.0066
224 SKIN ABRASION 31 0.0066
225 NEGATIVE THOUGHTS 19 0.0065
226 BEHAVIOUR DISORDER 35 0.0065
227 HEPATIC ENZYME INCREASED 441 0.0065
228 SKIN WEEPING 23 0.0064
229 ANGER 218 0.0064
230 AGGRESSION 322 0.0064
231 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 35 0.0064
232 RENAL DISORDER 297 0.0064
233 SNORING 24 0.0063
234 INFUSION RELATED REACTION 420 0.0063
235 CONCUSSION 49 0.0063
236 GOUT 113 0.0063
237 EAR PRURITUS 22 0.0063
238 SLEEP DISORDER 439 0.0062
239 OXYGEN SATURATION DECREASED 345 0.0061
240 EYE INFECTION 69 0.0061
241 TOOTH ABSCESS 62 0.0061
242 SWELLING OF EYELID 38 0.0060
243 PRODUCT DISTRIBUTION ISSUE 56 0.0060
244 SUICIDAL BEHAVIOUR 25 0.0060
245 CHOKING SENSATION 33 0.0060
246 FLANK PAIN 56 0.0060
247 SCRATCH 63 0.0060
248 RESPIRATORY RATE INCREASED 53 0.0060
249 PSYCHOMOTOR HYPERACTIVITY 99 0.0060
250 DYSPHEMIA 26 0.0059
251 THROAT CLEARING 22 0.0059
252 DYSPNOEA 3295 0.0058
253 POST-TRAUMATIC STRESS DISORDER 39 0.0058
254 CANDIDA INFECTION 98 0.0058
255 ECZEMA 303 0.0058
256 GRANULOMA 20 0.0058
257 APHONIA 80 0.0057
258 MOOD ALTERED 156 0.0057
259 FACIAL PAIN 51 0.0057
260 ILLNESS 587 0.0057
261 WEIGHT FLUCTUATION 59 0.0056
262 RHINORRHOEA 364 0.0056
263 SHOULDER OPERATION 24 0.0056
264 EYE PAIN 316 0.0056
265 HEREDITARY ANGIOEDEMA 60 0.0056
266 SINUS HEADACHE 33 0.0055
267 QUALITY OF LIFE DECREASED 74 0.0055
268 VASCULAR DEVICE INFECTION 25 0.0055
269 BURNING SENSATION 386 0.0055
270 ASPIRATION 60 0.0055
271 SARCOIDOSIS 26 0.0055
272 NEPHROPATHY 51 0.0055
273 HYSTERECTOMY 47 0.0054
274 LIGAMENT SPRAIN 53 0.0054
275 HYPERVENTILATION 31 0.0053
276 SPINAL STENOSIS 22 0.0053
277 EYE PRURITUS 179 0.0053
278 SENSITIVITY TO WEATHER CHANGE 28 0.0053
279 INFLUENZA 593 0.0053
280 GASTROENTERITIS VIRAL 96 0.0053
281 DEPRESSED MOOD 281 0.0053
282 PERIORBITAL SWELLING 30 0.0053
283 DERMATITIS ATOPIC 275 0.0052
284 SCREAMING 33 0.0052
285 SYMPTOM RECURRENCE 31 0.0052
286 RETCHING 110 0.0052
287 LEFT VENTRICULAR HYPERTROPHY 22 0.0051
288 TEARFULNESS 22 0.0051
289 IRON DEFICIENCY ANAEMIA 47 0.0051
290 AFFECTIVE DISORDER 40 0.0051
291 OBESITY 81 0.0051
292 HYPERTENSION 1075 0.0051
293 PERSONALITY CHANGE 47 0.0051
294 PNEUMONIA 1638 0.0051
295 PULMONARY THROMBOSIS 55 0.0050
296 DYSPHONIA 293 0.0050
297 ARTHROPOD BITE 37 0.0050
298 SKIN INFECTION 56 0.0050
299 BACTERIAL INFECTION 93 0.0050
300 EAR DISCOMFORT 51 0.0050
301 SKIN SWELLING 43 0.0049
302 VITAMIN B12 DEFICIENCY 20 0.0049
303 HYPERSENSITIVITY 916 0.0049
304 DIVERTICULUM 35 0.0049
305 SKIN HAEMORRHAGE 73 0.0049
306 BLOOD PRESSURE SYSTOLIC INCREASED 96 0.0049
307 GLUCOSE TOLERANCE IMPAIRED 29 0.0049
308 FOREIGN BODY SENSATION IN EYES 31 0.0049
309 SKIN PLAQUE 41 0.0049
310 HYPERVOLAEMIA 24 0.0049
311 BRAIN FOG 76 0.0048
312 TEMPERATURE INTOLERANCE 50 0.0048
313 ANKLE FRACTURE 75 0.0048
314 FUNGAL INFECTION 160 0.0048
315 PHOTOPHOBIA 90 0.0048
316 EXPOSURE VIA SKIN CONTACT 124 0.0048
317 TRICUSPID VALVE INCOMPETENCE 38 0.0048
318 VIRAL INFECTION 159 0.0048
319 HYPERCHOLESTEROLAEMIA 46 0.0048
320 ABNORMAL BEHAVIOUR 188 0.0047
321 POOR QUALITY SLEEP 102 0.0047
322 BLEPHARITIS 19 0.0047
323 CARDIAC DISORDER 443 0.0047
324 PHARYNGITIS STREPTOCOCCAL 51 0.0047
325 INCORRECT DRUG ADMINISTRATION RATE 20 0.0047
326 OSTEOPOROSIS 191 0.0046
327 PARANOIA 80 0.0046
328 EYE DISCHARGE 48 0.0046
329 DRUG INTOLERANCE 446 0.0046
330 SENSITIVE SKIN 34 0.0046
331 INFECTION 667 0.0046
332 INTENTIONAL PRODUCT MISUSE 403 0.0046
333 HYPERHIDROSIS 593 0.0046
334 OROPHARYNGEAL PAIN 426 0.0046
335 EAR DISORDER 21 0.0046
336 INITIAL INSOMNIA 47 0.0046
337 RESPIRATORY DISORDER 137 0.0046
338 BODY TEMPERATURE DECREASED 45 0.0046
339 PRODUCT DOSE OMISSION IN ERROR 129 0.0046
340 TYPE 2 DIABETES MELLITUS 153 0.0045
341 LIGAMENT RUPTURE 20 0.0045
342 COVID-19 794 0.0045
343 EXERCISE TOLERANCE DECREASED 26 0.0045
344 ABNORMAL DREAMS 123 0.0045
345 EAR PAIN 86 0.0044
346 ANOSMIA 64 0.0044
347 TOOTH INFECTION 58 0.0044
348 MAJOR DEPRESSION 32 0.0044
349 CONCOMITANT DISEASE AGGRAVATED 27 0.0044
350 SKIN FISSURES 85 0.0043
351 THROAT IRRITATION 195 0.0043
352 NASOPHARYNGITIS 800 0.0043
353 BACK INJURY 47 0.0043
354 NEPHROGENIC ANAEMIA 20 0.0043
355 SQUAMOUS CELL CARCINOMA OF SKIN 26 0.0043
356 ROSACEA 20 0.0043
357 HALLUCINATION, AUDITORY 68 0.0043
358 HYPOGAMMAGLOBULINAEMIA 28 0.0043
359 ANXIETY 1211 0.0043
360 SKIN LACERATION 46 0.0042
361 CONJUNCTIVITIS 78 0.0042
362 INFUSION SITE EXTRAVASATION 26 0.0042
363 BLOOD LACTIC ACID INCREASED 22 0.0042
364 INTENTIONAL DOSE OMISSION 118 0.0041
365 DIZZINESS POSTURAL 40 0.0041
366 URTICARIA 689 0.0041
367 VITAMIN D DEFICIENCY 40 0.0041
368 RHEUMATOID ARTHRITIS 465 0.0041
369 ERYTHEMA OF EYELID 22 0.0041
370 DRY EYE 202 0.0040
371 CRYING 147 0.0040
372 PERIORBITAL OEDEMA 21 0.0040
373 THERAPEUTIC RESPONSE SHORTENED 133 0.0040
374 MUSCULOSKELETAL CHEST PAIN 62 0.0040
375 CHOKING 78 0.0040
376 VIRAL UPPER RESPIRATORY TRACT INFECTION 19 0.0040
377 SKIN ATROPHY 23 0.0040
378 JOINT SWELLING 481 0.0040
379 PANIC ATTACK 145 0.0040
380 PAPULE 28 0.0040
381 POOR VENOUS ACCESS 41 0.0040
382 PRODUCT DOSE OMISSION ISSUE 1162 0.0039
383 PRODUCT USE ISSUE 740 0.0039
384 CARDIOMYOPATHY 58 0.0039
385 NERVE COMPRESSION 36 0.0039
386 MIGRAINE 371 0.0039
387 ANAPHYLACTIC REACTION 214 0.0039
388 THINKING ABNORMAL 72 0.0039
389 BIPOLAR DISORDER 42 0.0039
390 MOOD SWINGS 123 0.0039
391 TENDERNESS 40 0.0038
392 ANGIOEDEMA 169 0.0038
393 ROTATOR CUFF SYNDROME 49 0.0038
394 LACRIMATION INCREASED 115 0.0038
395 LIMB INJURY 103 0.0038
396 PHARYNGITIS 47 0.0038
397 SUICIDAL IDEATION 346 0.0038
398 SPINAL OPERATION 46 0.0037
399 HEADACHE 2341 0.0037
400 DECREASED INTEREST 22 0.0037
401 BLOOD IRON DECREASED 44 0.0037
402 NEURALGIA 90 0.0037
403 JOINT INJURY 79 0.0037
404 PHOTOSENSITIVITY REACTION 61 0.0037
405 AUTOIMMUNE DISORDER 36 0.0037
406 GLAUCOMA 71 0.0037
407 THERAPEUTIC RESPONSE DECREASED 220 0.0036
408 DISCOMFORT 221 0.0036
409 PSEUDOMONAS INFECTION 31 0.0036
410 PERIPHERAL COLDNESS 49 0.0036
411 KIDNEY INFECTION 70 0.0036
412 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 18 0.0036
413 DRY THROAT 36 0.0035
414 LIVER FUNCTION TEST INCREASED 76 0.0035
415 INJECTION SITE DISCHARGE 19 0.0035
416 TREATMENT FAILURE 292 0.0035
417 DERMATITIS ALLERGIC 44 0.0035
418 ORAL HERPES 68 0.0035
419 PRODUCT USE IN UNAPPROVED INDICATION 858 0.0035
420 POST PROCEDURAL INFECTION 28 0.0034
421 HYPERGLYCAEMIA 125 0.0034
422 EATING DISORDER 73 0.0034
423 ORAL CANDIDIASIS 45 0.0034
424 OCULAR HYPERAEMIA 162 0.0034
425 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 30 0.0034
426 COMPRESSION FRACTURE 18 0.0034
427 BRUXISM 18 0.0033
428 PULMONARY CONGESTION 44 0.0033
429 WRIST FRACTURE 40 0.0033
430 DEPRESSION 758 0.0033
431 INTENTIONAL SELF-INJURY 67 0.0033
432 DRUG EFFECT LESS THAN EXPECTED 49 0.0033
433 RIB FRACTURE 68 0.0033
434 FORMICATION 23 0.0033
435 IMPAIRED GASTRIC EMPTYING 45 0.0033
436 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 593 0.0033
437 WOUND INFECTION 36 0.0033
438 VITAMIN D DECREASED 28 0.0033
439 PYREXIA 1132 0.0033
440 CYSTITIS 104 0.0033
441 IMMUNE SYSTEM DISORDER 43 0.0033
442 INCREASED TENDENCY TO BRUISE 30 0.0033
443 HEART RATE INCREASED 321 0.0032
444 MUSCLE STRAIN 28 0.0032
445 THROMBOCYTOPENIA 361 0.0032
446 CONSTIPATION 703 0.0032
447 INJECTION SITE URTICARIA 79 0.0032
448 COVID-19 PNEUMONIA 38 0.0032
449 IRRITABLE BOWEL SYNDROME 69 0.0032
450 JOINT DISLOCATION 34 0.0032
451 POLYP 21 0.0032
452 SCIATICA 51 0.0032
453 CHEST PAIN 588 0.0032
454 IRRITABILITY 190 0.0032
455 CHOLECYSTECTOMY 36 0.0031
456 PRURITUS 1208 0.0031
457 GINGIVAL PAIN 25 0.0031
458 INJECTION SITE VESICLES 19 0.0031
459 SKIN LESION 86 0.0031
460 THROMBOSIS 252 0.0031
461 HAND FRACTURE 22 0.0031
462 EYE SWELLING 115 0.0031
463 OSTEOARTHRITIS 131 0.0031
464 BODY HEIGHT DECREASED 33 0.0031
465 BACK PAIN 716 0.0031
466 BACK DISORDER 50 0.0031
467 THROAT TIGHTNESS 83 0.0031
468 HEPATIC STEATOSIS 57 0.0031
469 BLOOD POTASSIUM DECREASED 92 0.0031
470 PAROSMIA 23 0.0030
471 CELLULITIS 153 0.0030
472 NASAL DRYNESS 19 0.0030
473 NASAL DISCOMFORT 24 0.0030
474 BLOOD PRESSURE INCREASED 462 0.0030
475 BLOOD PRESSURE ABNORMAL 60 0.0030
476 ACCIDENT 36 0.0030
477 AFFECT LABILITY 29 0.0030
478 BLOOD MAGNESIUM DECREASED 26 0.0030
479 HYPERLIPIDAEMIA 36 0.0030
480 GASTROINTESTINAL INFECTION 27 0.0030
481 HERPES ZOSTER 173 0.0030
482 URINARY TRACT INFECTION 510 0.0030
483 EYE IRRITATION 172 0.0030
484 INSOMNIA 793 0.0030
485 CATARACT 177 0.0030
486 PETECHIAE 31 0.0030
487 RESTLESS LEGS SYNDROME 54 0.0030
488 AGITATION 218 0.0030
489 OEDEMA PERIPHERAL 361 0.0030
490 ERYTHEMA 608 0.0030
491 THERAPY PARTIAL RESPONDER 46 0.0029
492 DECUBITUS ULCER 24 0.0029
493 CARDIOMEGALY 36 0.0029
494 PERIPHERAL SWELLING 450 0.0029
495 MALAISE 1280 0.0029
496 SURGERY 171 0.0029
497 FATIGUE 2269 0.0029
498 FOOT FRACTURE 55 0.0029
499 CONTUSION 279 0.0029
500 RASH 1261 0.0029
501 BLOOD PRESSURE DECREASED 192 0.0029
502 VERTIGO 176 0.0029
503 DIVERTICULITIS 80 0.0029
504 STAPHYLOCOCCAL INFECTION 95 0.0029
505 PSORIASIS 376 0.0029
506 SARS-COV-2 TEST POSITIVE 38 0.0029
507 SENSORY DISTURBANCE 46 0.0029
508 HALLUCINATION 216 0.0029
509 NAIL DISORDER 25 0.0029
510 FRUSTRATION TOLERANCE DECREASED 23 0.0028
511 SKIN MASS 19 0.0028
512 NECK PAIN 159 0.0028
513 MUSCLE DISORDER 23 0.0028
514 RASH MACULAR 99 0.0028
515 HYPERSOMNIA 81 0.0028
516 SKIN EXFOLIATION 238 0.0028
517 SUPRAVENTRICULAR TACHYCARDIA 27 0.0028
518 ASPHYXIA 23 0.0028
519 PAIN 1729 0.0028
520 CONDITION AGGRAVATED 854 0.0028
521 ACUTE RESPIRATORY FAILURE 54 0.0028
522 NOCTURIA 34 0.0028
523 SWELLING 262 0.0028
524 THIRST 50 0.0028
525 END STAGE RENAL DISEASE 51 0.0028
526 ABNORMAL LOSS OF WEIGHT 19 0.0028
527 EPISTAXIS 208 0.0028
528 DRY SKIN 371 0.0028
529 CHOLELITHIASIS 91 0.0028
530 INJECTION SITE RASH 85 0.0028
531 LYMPHOEDEMA 19 0.0027
532 HYPOACUSIS 118 0.0027
533 PULMONARY HYPERTENSION 57 0.0027
534 MUSCULOSKELETAL DISCOMFORT 47 0.0027
535 PRODUCT USE COMPLAINT 43 0.0027
536 MYASTHENIA GRAVIS 22 0.0027
537 PRODUCT ADMINISTRATION ERROR 55 0.0027
538 WEIGHT INCREASED 609 0.0027
539 ADRENAL INSUFFICIENCY 33 0.0027
540 INTERNAL HAEMORRHAGE 31 0.0027
541 HEAD DISCOMFORT 48 0.0027
542 PROCEDURAL PAIN 75 0.0027
543 MENTAL DISORDER 117 0.0027
544 SINUS TACHYCARDIA 38 0.0027
545 GASTROENTERITIS 39 0.0027
546 ATRIAL FIBRILLATION 259 0.0027
547 WEIGHT DECREASED 742 0.0027
548 TRANSAMINASES INCREASED 59 0.0027
549 PAIN IN EXTREMITY 781 0.0026
550 HOSPITALISATION 407 0.0026
551 AGEUSIA 66 0.0026
552 INJECTION SITE PRURITUS 177 0.0026
553 SPINAL DISORDER 25 0.0026
554 FEAR 71 0.0026
555 EYE INFLAMMATION 25 0.0026
556 PAIN IN JAW 74 0.0026
557 BOWEL MOVEMENT IRREGULARITY 20 0.0026
558 SENSATION OF FOREIGN BODY 22 0.0026
559 PULMONARY EMBOLISM 248 0.0026
560 DISSOCIATION 20 0.0026
561 PSYCHOTIC DISORDER 77 0.0026
562 INJECTION SITE IRRITATION 33 0.0026
563 HEAD INJURY 82 0.0026
564 LUNG INFECTION 40 0.0026
565 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 44 0.0026
566 PRESYNCOPE 62 0.0025
567 NIGHT SWEATS 82 0.0025
568 KNEE OPERATION 25 0.0025
569 MICTURITION URGENCY 29 0.0025
570 MUSCLE TIGHTNESS 41 0.0025
571 CHRONIC KIDNEY DISEASE 192 0.0025
572 LOCALISED INFECTION 61 0.0025
573 BLADDER DISORDER 25 0.0025
574 SCAR 43 0.0025
575 IMMUNOSUPPRESSION 22 0.0025
576 PALPITATIONS 292 0.0025
577 ARTHRITIS 196 0.0025
578 TRANSIENT ISCHAEMIC ATTACK 84 0.0025
579 NEPHROLITHIASIS 114 0.0025
580 FULL BLOOD COUNT DECREASED 50 0.0025
581 GASTROINTESTINAL DISORDER 222 0.0025
582 INTERVERTEBRAL DISC PROTRUSION 54 0.0025
583 SWOLLEN TONGUE 77 0.0025
584 LIP SWELLING 82 0.0025
585 LIMB DISCOMFORT 76 0.0025
586 SCAB 28 0.0025
587 RASH PRURITIC 133 0.0025
588 SLUGGISHNESS 25 0.0024
589 WHITE BLOOD CELL COUNT INCREASED 94 0.0024
590 DISTURBANCE IN ATTENTION 132 0.0024
591 MUSCLE SPASMS 448 0.0024
592 INTENTIONAL PRODUCT USE ISSUE 213 0.0024
593 MYOPATHY 21 0.0024
594 PARAESTHESIA ORAL 35 0.0024
595 KNEE ARTHROPLASTY 51 0.0024
596 ABDOMINAL DISCOMFORT 406 0.0024
597 FALL 804 0.0024
598 DIZZINESS 1201 0.0024
599 TREMOR 399 0.0024
600 INJECTION SITE SWELLING 184 0.0024
601 SALIVARY HYPERSECRETION 24 0.0024
602 POST PROCEDURAL COMPLICATION 46 0.0024
603 NERVOUSNESS 125 0.0024
604 VISION BLURRED 328 0.0024
605 BLOOD SODIUM DECREASED 45 0.0024
606 INJECTION SITE PAIN 732 0.0024
607 SOMNOLENCE 479 0.0024
608 HOT FLUSH 179 0.0024
609 HALLUCINATION, VISUAL 50 0.0024
610 EMOTIONAL DISORDER 73 0.0024
611 FEEDING DISORDER 48 0.0024
612 TASTE DISORDER 48 0.0024
613 FEELING HOT 145 0.0024
614 THERAPEUTIC RESPONSE UNEXPECTED 106 0.0024
615 FEELING JITTERY 45 0.0024
616 UPPER LIMB FRACTURE 47 0.0024
617 DYSPEPSIA 232 0.0024
618 VOMITING 1104 0.0023
619 MACULAR DEGENERATION 28 0.0023
620 MUSCLE TWITCHING 54 0.0023
621 FEELING COLD 65 0.0023
622 CHILLS 273 0.0023
623 SKIN DISCOLOURATION 107 0.0023
624 ADVERSE DRUG REACTION 209 0.0023
625 ORAL PAIN 52 0.0023
626 OSTEOPENIA 35 0.0023
627 HEART RATE IRREGULAR 52 0.0023
628 BLOOD PRESSURE FLUCTUATION 55 0.0023
629 RESPIRATORY FAILURE 167 0.0023
630 OESOPHAGITIS 25 0.0023
631 RESPIRATORY DEPRESSION 28 0.0023
632 INJECTION SITE BRUISING 182 0.0023
633 HEART RATE DECREASED 80 0.0023
634 SPINAL OSTEOARTHRITIS 20 0.0023
635 GRIP STRENGTH DECREASED 20 0.0023
636 ABDOMINAL DISTENSION 237 0.0023
637 THERAPY NON-RESPONDER 102 0.0023
638 HYPOAESTHESIA 339 0.0023
639 TOOTHACHE 41 0.0023
640 PURPURA 20 0.0023
641 ATRIAL FLUTTER 18 0.0023
642 CARDIAC FAILURE CONGESTIVE 181 0.0023
643 MUSCULOSKELETAL STIFFNESS 197 0.0022
644 SKIN DISORDER 75 0.0022
645 DRY MOUTH 182 0.0022
646 GASTRITIS 59 0.0022
647 VITREOUS FLOATERS 22 0.0022
648 NEUROPATHY PERIPHERAL 212 0.0022
649 ARTHRALGIA 925 0.0022
650 TINNITUS 102 0.0022
651 BONE PAIN 130 0.0022
652 AMNESIA 144 0.0022
653 SWELLING FACE 144 0.0022
654 ANAPHYLACTIC SHOCK 57 0.0022
655 PNEUMOTHORAX 35 0.0022
656 TOOTH DISORDER 49 0.0022
657 HAEMATOMA 57 0.0022
658 PRODUCT AVAILABILITY ISSUE 50 0.0022
659 DISEASE RECURRENCE 104 0.0022
660 BALANCE DISORDER 188 0.0022
661 RESPIRATORY DISTRESS 60 0.0022
662 ATELECTASIS 21 0.0022
663 FEELING ABNORMAL 520 0.0022
664 MEMORY IMPAIRMENT 298 0.0022
665 NAUSEA 1713 0.0022
666 FLUSHING 220 0.0022
667 ANGINA PECTORIS 62 0.0022
668 CYANOSIS 34 0.0022
669 EYE DISORDER 71 0.0022
670 BLISTER 121 0.0022
671 ROAD TRAFFIC ACCIDENT 90 0.0021
672 LUNG INFILTRATION 19 0.0021
673 ABDOMINAL PAIN UPPER 441 0.0021
674 GAIT DISTURBANCE 409 0.0021
675 HEPATOMEGALY 21 0.0021
676 PARAESTHESIA 336 0.0021
677 TENDONITIS 33 0.0021
678 MUSCULAR WEAKNESS 242 0.0021
679 TACHYCARDIA 189 0.0021
680 LETHARGY 121 0.0021
681 DIARRHOEA 1357 0.0021
682 FOLLICULITIS 22 0.0021
683 ASTHENIA 783 0.0021
684 INJECTION SITE DISCOLOURATION 26 0.0021
685 FLATULENCE 118 0.0021
686 INFLUENZA LIKE ILLNESS 171 0.0021
687 THYROID DISORDER 32 0.0021
688 HERNIA 40 0.0021
689 NEEDLE ISSUE 60 0.0021
690 APATHY 30 0.0021
691 PLEURAL EFFUSION 125 0.0021
692 CHROMATURIA 46 0.0020
693 REBOUND EFFECT 23 0.0020
694 INJECTION SITE ERYTHEMA 251 0.0020
695 RESTLESSNESS 74 0.0020
696 THERAPY INTERRUPTED 144 0.0020
697 CYST 25 0.0020
698 ULCER 32 0.0020
699 SPINAL FRACTURE 40 0.0020
700 DENTAL CARIES 22 0.0020
701 DYSSTASIA 58 0.0020
702 DYSPHAGIA 187 0.0020
703 LYMPHADENOPATHY 69 0.0019
704 HUNGER 27 0.0019
705 TOOTH EXTRACTION 24 0.0019
706 HOSPICE CARE 19 0.0019
707 PNEUMONIA ASPIRATION 48 0.0019
708 PRODUCT TASTE ABNORMAL 26 0.0019
709 PLATELET COUNT INCREASED 25 0.0019
710 GAIT INABILITY 64 0.0019
711 OVERDOSE 413 0.0019
712 MATERNAL EXPOSURE DURING PREGNANCY 169 0.0019
713 MYALGIA 322 0.0019
714 DEVICE USE ISSUE 33 0.0019
715 COLD SWEAT 33 0.0019
716 DISORIENTATION 74 0.0019
717 BLOOD CHOLESTEROL INCREASED 87 0.0019
718 COORDINATION ABNORMAL 26 0.0019
719 DERMATITIS 39 0.0019
720 SYSTEMIC LUPUS ERYTHEMATOSUS 66 0.0019
721 GALLBLADDER DISORDER 33 0.0018
722 INCREASED APPETITE 35 0.0018
723 DECREASED APPETITE 424 0.0018
724 PRODUCT SUBSTITUTION ISSUE 105 0.0018
725 LOWER LIMB FRACTURE 35 0.0018
726 CARDIAC FAILURE 146 0.0018
727 ADVERSE EVENT 166 0.0018
728 DEHYDRATION 240 0.0018
729 EYE HAEMORRHAGE 24 0.0018
730 STOMATITIS 109 0.0018
731 PRODUCT PRESCRIBING ISSUE 39 0.0018
732 BLOOD POTASSIUM INCREASED 29 0.0018
733 ILL-DEFINED DISORDER 108 0.0018
734 POLLAKIURIA 74 0.0018
735 DIPLOPIA 46 0.0018
736 DISABILITY 35 0.0018
737 INFLAMMATION 91 0.0018
738 HIP ARTHROPLASTY 27 0.0018
739 PNEUMONITIS 48 0.0018
740 IMPAIRED DRIVING ABILITY 20 0.0018
741 PRODUCT PREPARATION ERROR 36 0.0018
742 DIABETES MELLITUS 133 0.0017
743 CLOSTRIDIUM DIFFICILE INFECTION 38 0.0017
744 HYPONATRAEMIA 98 0.0017
745 DYSURIA 64 0.0017
746 IMPAIRED WORK ABILITY 37 0.0017
747 INJECTION SITE MASS 64 0.0017
748 PERICARDIAL EFFUSION 40 0.0017
749 ABDOMINAL PAIN 402 0.0017
750 DRUG INEFFECTIVE 2277 0.0017
751 GASTROINTESTINAL PAIN 19 0.0017
752 COMPLICATION ASSOCIATED WITH DEVICE 25 0.0017
753 ECONOMIC PROBLEM 26 0.0017
754 RED BLOOD CELL COUNT DECREASED 49 0.0017
755 NERVE INJURY 19 0.0017
756 TENDON RUPTURE 21 0.0017
757 ABNORMAL WEIGHT GAIN 21 0.0017
758 GENERALISED OEDEMA 21 0.0017
759 HYPOTENSION 340 0.0017
760 DRUG ERUPTION 30 0.0017
761 HYPOCALCAEMIA 32 0.0017
762 PHARYNGEAL OEDEMA 26 0.0017
763 LOSS OF CONSCIOUSNESS 216 0.0017
764 CONFUSIONAL STATE 272 0.0017
765 PULMONARY OEDEMA 75 0.0017
766 NEUTROPHIL COUNT DECREASED 68 0.0017
767 BODY TEMPERATURE INCREASED 34 0.0017
768 ADVERSE REACTION 22 0.0017
769 DRUG-INDUCED LIVER INJURY 52 0.0017
770 UNEVALUABLE EVENT 125 0.0017
771 SCHIZOPHRENIA 20 0.0016
772 MOBILITY DECREASED 118 0.0016
773 JOINT RANGE OF MOTION DECREASED 22 0.0016
774 DEVICE OCCLUSION 23 0.0016
775 URINARY INCONTINENCE 48 0.0016
776 FAECES DISCOLOURED 35 0.0016
777 GINGIVAL BLEEDING 22 0.0016
778 GLOSSODYNIA 36 0.0016
779 WHITE BLOOD CELL COUNT DECREASED 174 0.0016
780 DRUG INTERACTION 253 0.0016
781 BLOOD CREATININE INCREASED 104 0.0016
782 HYPOAESTHESIA ORAL 24 0.0016
783 OFF LABEL USE 1391 0.0016
784 MEDICATION ERROR 88 0.0016
785 MANIA 26 0.0016
786 PLATELET COUNT DECREASED 167 0.0016
787 URINARY RETENTION 52 0.0016
788 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
789 PULMONARY ARTERIAL HYPERTENSION 22 0.0015
790 VISUAL IMPAIRMENT 187 0.0015
791 SKIN ULCER 39 0.0015
792 PREMATURE DELIVERY 24 0.0015
793 THERAPEUTIC PRODUCT EFFECT DECREASED 67 0.0015
794 MOVEMENT DISORDER 48 0.0015
795 PANCREATITIS 79 0.0015
796 ARTHROPATHY 83 0.0015
797 MALIGNANT MELANOMA 20 0.0015
798 HIP FRACTURE 48 0.0015
799 SKIN CANCER 32 0.0015
800 PSORIATIC ARTHROPATHY 60 0.0015
801 DEEP VEIN THROMBOSIS 96 0.0015
802 SPEECH DISORDER 77 0.0015
803 WOUND 41 0.0015
804 HAEMATOCRIT DECREASED 29 0.0015
805 DEAFNESS 38 0.0015
806 DYSKINESIA 59 0.0015
807 ACCIDENTAL EXPOSURE TO PRODUCT 149 0.0014
808 LIVER FUNCTION TEST ABNORMAL 42 0.0014
809 ORAL DISCOMFORT 20 0.0014
810 SEPSIS 160 0.0014
811 ALOPECIA 279 0.0014
812 SUICIDE ATTEMPT 86 0.0014
813 LEUKOPENIA 70 0.0014
814 SYNCOPE 140 0.0014
815 PARALYSIS 20 0.0014
816 ERUCTATION 27 0.0014
817 INJECTION SITE REACTION 96 0.0014
818 ACUTE KIDNEY INJURY 212 0.0014
819 INCORRECT PRODUCT ADMINISTRATION DURATION 30 0.0014
820 RASH PAPULAR 31 0.0014
821 ARRHYTHMIA 65 0.0014
822 DEVICE RELATED INFECTION 21 0.0014
823 SEIZURE 157 0.0014
824 APHASIA 41 0.0014
825 WITHDRAWAL SYNDROME 57 0.0014
826 SKIN REACTION 19 0.0013
827 HAEMATOCHEZIA 74 0.0013
828 GASTRIC DISORDER 46 0.0013
829 JOINT STIFFNESS 35 0.0013
830 MENTAL STATUS CHANGES 37 0.0013
831 MOUTH ULCERATION 28 0.0013
832 LABORATORY TEST ABNORMAL 39 0.0013
833 TREATMENT NONCOMPLIANCE 72 0.0013
834 DEVICE FAILURE 20 0.0013
835 FACE OEDEMA 22 0.0013
836 DYSARTHRIA 49 0.0013
837 ANAEMIA 248 0.0013
838 PRURITUS GENERALISED 28 0.0013
839 THERAPY CESSATION 66 0.0013
840 COGNITIVE DISORDER 60 0.0013
841 HAEMORRHOIDS 25 0.0013
842 BLINDNESS UNILATERAL 18 0.0013
843 VENTRICULAR TACHYCARDIA 21 0.0013
844 LEUKOCYTOSIS 23 0.0013
845 BLOOD GLUCOSE DECREASED 61 0.0013
846 GENERALISED TONIC-CLONIC SEIZURE 21 0.0013
847 INJURY 89 0.0013
848 RENAL FAILURE 168 0.0013
849 BLOOD LACTATE DEHYDROGENASE INCREASED 20 0.0013
850 HYPOKALAEMIA 58 0.0013
851 DEMENTIA 35 0.0013
852 PALLOR 34 0.0012
853 INTESTINAL OBSTRUCTION 47 0.0012
854 MENTAL IMPAIRMENT 30 0.0012
855 HYPOGLYCAEMIA 60 0.0012
856 EMOTIONAL DISTRESS 149 0.0012
857 PLASMA CELL MYELOMA 48 0.0012
858 GENERAL PHYSICAL HEALTH DETERIORATION 142 0.0012
859 TUBULOINTERSTITIAL NEPHRITIS 23 0.0012
860 PRODUCT DOSE OMISSION 80 0.0012
861 FREQUENT BOWEL MOVEMENTS 33 0.0012
862 ACTIVITIES OF DAILY LIVING IMPAIRED 24 0.0012
863 GASTRIC ULCER 23 0.0012
864 ORTHOSTATIC HYPOTENSION 21 0.0012
865 SKIN IRRITATION 55 0.0012
866 INTERSTITIAL LUNG DISEASE 58 0.0012
867 ELECTROCARDIOGRAM QT PROLONGED 43 0.0012
868 LIVER DISORDER 53 0.0012
869 PRODUCT PRESCRIBING ERROR 28 0.0012
870 GASTROINTESTINAL HAEMORRHAGE 98 0.0012
871 DYSGEUSIA 87 0.0012
872 ASPARTATE AMINOTRANSFERASE INCREASED 62 0.0012
873 OSTEOMYELITIS 21 0.0012
874 HAEMOGLOBIN DECREASED 119 0.0012
875 MULTIPLE FRACTURES 19 0.0012
876 PAIN OF SKIN 31 0.0012
877 INCORRECT DOSE ADMINISTERED 262 0.0011
878 EXTRA DOSE ADMINISTERED 46 0.0011
879 COLITIS 43 0.0011
880 HEPATITIS 29 0.0011
881 SHOCK 26 0.0011
882 HEPATIC FUNCTION ABNORMAL 42 0.0011
883 HEPATIC CIRRHOSIS 21 0.0011
884 LACTIC ACIDOSIS 36 0.0011
885 NEOPLASM MALIGNANT 74 0.0011
886 BLOOD URINE PRESENT 21 0.0011
887 ANHEDONIA 29 0.0011
888 BONE DISORDER 20 0.0011
889 PRODUCT QUALITY ISSUE 149 0.0011
890 IMPAIRED HEALING 36 0.0011
891 MELAENA 24 0.0011
892 MUSCULOSKELETAL PAIN 57 0.0011
893 BLOOD GLUCOSE ABNORMAL 20 0.0011
894 HAEMORRHAGE 113 0.0011
895 COAGULOPATHY 18 0.0011
896 EPILEPSY 33 0.0011
897 GLYCOSYLATED HAEMOGLOBIN INCREASED 27 0.0011
898 HYPERKALAEMIA 37 0.0011
899 MUSCULOSKELETAL DISORDER 20 0.0010
900 ALANINE AMINOTRANSFERASE INCREASED 64 0.0010
901 BRADYCARDIA 55 0.0010
902 LUNG NEOPLASM MALIGNANT 42 0.0010
903 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 56 0.0010
904 SKIN BURNING SENSATION 73 0.0010
905 INTERNATIONAL NORMALISED RATIO INCREASED 29 0.0010
906 HYPOPHAGIA 26 0.0010
907 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
908 RASH GENERALISED 26 0.0010
909 NERVOUS SYSTEM DISORDER 31 0.0010
910 SEDATION 26 0.0010
911 PANCREATITIS ACUTE 22 0.0010
912 ACNE 74 0.0010
913 UNDERDOSE 71 0.0010
914 PRODUCT DISPENSING ERROR 21 0.0010
915 INJECTION SITE HAEMORRHAGE 77 0.0010
916 BLOOD BILIRUBIN INCREASED 26 0.0010
917 MULTIPLE SCLEROSIS RELAPSE 65 0.0009
918 HAEMATEMESIS 24 0.0009
919 HEPATOTOXICITY 21 0.0009
920 RENAL INJURY 28 0.0009
921 PRODUCT PHYSICAL ISSUE 19 0.0009
922 RENAL IMPAIRMENT 79 0.0009
923 CEREBROVASCULAR ACCIDENT 159 0.0009
924 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 190 0.0009
925 ENCEPHALOPATHY 23 0.0009
926 C-REACTIVE PROTEIN INCREASED 34 0.0009
927 CORONARY ARTERY DISEASE 28 0.0009
928 INJECTION SITE WARMTH 19 0.0009
929 MULTIPLE SCLEROSIS 44 0.0009
930 DEVICE ISSUE 81 0.0009
931 EXTRAPYRAMIDAL DISORDER 22 0.0009
932 BLOOD GLUCOSE INCREASED 165 0.0009
933 FEMUR FRACTURE 27 0.0009
934 RECTAL HAEMORRHAGE 37 0.0009
935 CEREBRAL HAEMORRHAGE 30 0.0008
936 CARDIAC ARREST 69 0.0008
937 DEVICE LEAKAGE 36 0.0008
938 COMPLETED SUICIDE 69 0.0008
939 OSTEONECROSIS 27 0.0008
940 HAEMATURIA 28 0.0008
941 ASCITES 24 0.0008
942 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21 0.0008
943 NO ADVERSE EVENT 146 0.0008
944 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 27 0.0008
945 JAUNDICE 21 0.0008
946 ERECTILE DYSFUNCTION 20 0.0008
947 COMA 37 0.0008
948 DEVICE DISLOCATION 33 0.0008
949 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35 0.0007
950 DEATH 635 0.0007
951 BLINDNESS 30 0.0007
952 DEPRESSED LEVEL OF CONSCIOUSNESS 29 0.0007
953 BLOOD ALKALINE PHOSPHATASE INCREASED 18 0.0007
954 METABOLIC ACIDOSIS 23 0.0007
955 DEVICE BREAKAGE 29 0.0007
956 SEPTIC SHOCK 31 0.0007
957 MULTIPLE ORGAN DYSFUNCTION SYNDROME 20 0.0007
958 CARDIO-RESPIRATORY ARREST 29 0.0007
959 DISEASE PROGRESSION 82 0.0007
960 DEVICE USE ERROR 24 0.0007
961 RESPIRATORY ARREST 19 0.0007
962 DRUG EFFECT INCOMPLETE 25 0.0007
963 PANCYTOPENIA 38 0.0007
964 RHABDOMYOLYSIS 28 0.0007
965 BONE DENSITY DECREASED 21 0.0007
966 DRUG EFFECT DECREASED 36 0.0007
967 HEPATIC FAILURE 20 0.0007
968 NEOPLASM PROGRESSION 22 0.0006
969 NEUTROPENIA 85 0.0006
970 DEVICE MALFUNCTION 43 0.0006
971 VISUAL ACUITY REDUCED 20 0.0006
972 COLITIS ULCERATIVE 26 0.0006
973 VAGINAL HAEMORRHAGE 25 0.0006
974 DRUG DOSE OMISSION 94 0.0006
975 MYOCARDIAL INFARCTION 98 0.0006
976 CONVULSION 31 0.0005
977 EXPIRED PRODUCT ADMINISTERED 18 0.0005
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 38 0.0005
979 BREAST CANCER 49 0.0005
980 RENAL FAILURE ACUTE 22 0.0005
981 ABORTION SPONTANEOUS 20 0.0005
982 INTENTIONAL OVERDOSE 31 0.0005
983 DRUG ABUSE 38 0.0005
984 FOETAL EXPOSURE DURING PREGNANCY 37 0.0005
985 FEBRILE NEUTROPENIA 29 0.0004
986 PRODUCT STORAGE ERROR 38 0.0004
987 DEVICE DIFFICULT TO USE 23 0.0003
988 DRUG WITHDRAWAL SYNDROME 27 0.0003
989 DRUG DEPENDENCE 47 0.0003
990 TOXICITY TO VARIOUS AGENTS 48 0.0003
991 MALIGNANT NEOPLASM PROGRESSION 28 0.0003
992 DRUG DOSE OMISSION BY DEVICE 20 0.0003
993 PROSTATE CANCER 19 0.0002